International Flavors & Fragrances Current Ratio 2010-2024 | IFF
Current and historical current ratio for International Flavors & Fragrances (IFF) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. International Flavors & Fragrances current ratio for the three months ending June 30, 2024 was 2.38.
| International Flavors & Fragrances Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$8.15B |
$3.43B |
2.38 |
| 2024-03-31 |
$6.41B |
$3.82B |
1.68 |
| 2023-12-31 |
$6.29B |
$3.76B |
1.68 |
| 2023-09-30 |
$6.39B |
$3.68B |
1.74 |
| 2023-06-30 |
$6.44B |
$3.93B |
1.64 |
| 2023-03-31 |
$7.44B |
$4.87B |
1.53 |
| 2022-12-31 |
$7.43B |
$3.73B |
1.99 |
| 2022-09-30 |
$6.49B |
$3.63B |
1.79 |
| 2022-06-30 |
$7.73B |
$4.72B |
1.64 |
| 2022-03-31 |
$7.51B |
$4.03B |
1.86 |
| 2021-12-31 |
$6.99B |
$3.63B |
1.92 |
| 2021-09-30 |
$7.13B |
$3.58B |
1.99 |
| 2021-06-30 |
$6.30B |
$3.23B |
1.95 |
| 2021-03-31 |
$6.17B |
$3.26B |
1.89 |
| 2020-12-31 |
$3.06B |
$1.90B |
1.61 |
| 2020-09-30 |
$2.95B |
$1.62B |
1.82 |
| 2020-06-30 |
$3.01B |
$1.34B |
2.24 |
| 2020-03-31 |
$2.82B |
$1.43B |
1.98 |
| 2019-12-31 |
$2.94B |
$1.55B |
1.90 |
| 2019-09-30 |
$2.90B |
$1.41B |
2.05 |
| 2019-06-30 |
$2.99B |
$1.15B |
2.60 |
| 2019-03-31 |
$2.93B |
$1.14B |
2.56 |
| 2018-12-31 |
$2.94B |
$1.13B |
2.61 |
| 2018-09-30 |
$6.95B |
$0.76B |
9.16 |
| 2018-06-30 |
$2.03B |
$0.70B |
2.90 |
| 2018-03-31 |
$1.97B |
$0.72B |
2.75 |
| 2017-12-31 |
$1.90B |
$0.77B |
2.47 |
| 2017-09-30 |
$1.85B |
$0.70B |
2.66 |
| 2017-06-30 |
$1.99B |
$0.86B |
2.32 |
| 2017-03-31 |
$1.71B |
$0.99B |
1.74 |
| 2016-12-31 |
$1.61B |
$0.90B |
1.79 |
| 2016-09-30 |
$1.86B |
$0.86B |
2.17 |
| 2016-06-30 |
$1.93B |
$0.69B |
2.80 |
| 2016-03-31 |
$1.89B |
$0.71B |
2.65 |
| 2015-12-31 |
$1.44B |
$0.73B |
1.98 |
| 2015-09-30 |
$1.64B |
$0.69B |
2.38 |
| 2015-06-30 |
$1.72B |
$0.52B |
3.29 |
| 2015-03-31 |
$1.76B |
$0.49B |
3.60 |
| 2014-12-31 |
$1.71B |
$0.52B |
3.30 |
| 2014-09-30 |
$1.71B |
$0.52B |
3.31 |
| 2014-06-30 |
$1.64B |
$0.47B |
3.51 |
| 2014-03-31 |
$1.57B |
$0.49B |
3.24 |
| 2013-12-31 |
$1.65B |
$0.56B |
2.95 |
| 2013-09-30 |
$1.63B |
$0.51B |
3.21 |
| 2013-06-30 |
$1.63B |
$0.57B |
2.88 |
| 2013-03-31 |
$1.54B |
$0.54B |
2.84 |
| 2012-12-31 |
$1.57B |
$0.63B |
2.50 |
| 2012-09-30 |
$1.39B |
$0.65B |
2.13 |
| 2012-06-30 |
$1.36B |
$0.51B |
2.69 |
| 2012-03-31 |
$1.35B |
$0.52B |
2.58 |
| 2011-12-31 |
$1.32B |
$0.57B |
2.33 |
| 2011-09-30 |
$1.38B |
$0.58B |
2.41 |
| 2011-06-30 |
$1.44B |
$0.63B |
2.29 |
| 2011-03-31 |
$1.39B |
$0.63B |
2.19 |
| 2010-12-31 |
$1.33B |
$0.66B |
2.01 |
| 2010-09-30 |
$1.33B |
$0.64B |
2.06 |
| 2010-06-30 |
$1.22B |
$0.50B |
2.47 |
| 2010-03-31 |
$1.17B |
$0.48B |
2.46 |
| 2009-12-31 |
$1.13B |
$0.48B |
2.33 |
| 2009-09-30 |
$1.19B |
$0.36B |
3.34 |
| 2009-06-30 |
$1.19B |
$0.41B |
2.91 |
| 2009-03-31 |
$1.05B |
$0.35B |
3.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$25.292B |
$11.479B |
|
Flavors & Fragrances is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. It has 4 business units: Nourish, Scent, Health & Biosciences and Pharma Solutions; comprising 3 platforms: Ingredients, Flavors & Food Designs. Ingredients provide texturizing solutions to the food industry, food protection solutions for food and beverage products, specialty soy & pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds & natural taste solutions, and value-added spices and seasoning ingredients. Food Designs offer savory solution products. Health & Biosciences includes, Health, Cultures & Food Enzymes, Home & Personal Care, Animal Nutrition, Grain Processing and Microbial Control, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Pharma Solutions produces cellulosics and alginates-based pharma excipients.
|
